MedPath
HSA Approval

Oxaliplatin Hospira 5mg/mL, 50mg/10mL

SIN13942P

Oxaliplatin Hospira 5mg/mL, 50mg/10mL

Oxaliplatin Hospira 5mg/mL, 50mg/10mL

April 1, 2011

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INFUSION, SOLUTION CONCENTRATE

INTRAVENOUS

Medical Information

L01XA03

oxaliplatin

Manufacturer Information

PFIZER PRIVATE LIMITED

Zydus Hospira Oncology Private Limited

Active Ingredients

Oxaliplatin

50mg

Oxaliplatin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oxaliplatin Hospira 5mg/mL, 50mg/10mL - HSA Approval | MedPath